Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial

BACKGROUND: The effectiveness of intermittent montelukast for wheeze in young children is unclear. We aimed to assess whether intermittent montelukast is better than placebo for treatment of wheeze in this age group. Because copy numbers of the Sp1-binding motif in the arachidonate 5-lipoxygenase (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Nwokoro, Chinedu, Pandya, Hitesh, Turner, Stephen, Eldridge, Sandra, Griffiths, Christopher J, Vulliamy, Tom, Price, David, Sanak, Marek, Holloway, John W, Brugha, Rossa, Koh, Lee, Dickson, Iain, Rutterford, Clare, Grigg, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189104/
https://www.ncbi.nlm.nih.gov/pubmed/25212745
http://dx.doi.org/10.1016/S2213-2600(14)70186-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189104/
https://www.ncbi.nlm.nih.gov/pubmed/25212745
http://dx.doi.org/10.1016/S2213-2600(14)70186-9

Ejemplares similares